Article
Current therapies and targets for type 2 diabetes mellitus
1 Sept 2018
Abstract excerpt
The prevalence of type 2 diabetes mellitus (T2DM) has been increasing at an alarming rate. With an increased understanding of the pathophysiology and pathogenesis of T2DM, various new therapeutic options have been developed to target different key defects in T2DM. Incremental innovations of existing therapies either through unprecedented drug combinations, modified drug molecules, or improved delivery systems are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
